Evidence map›Paper›PMID 9986868›Full record

ArticleJournal of clinical microbiology1999

Identification of contaminating fungal DNA sequences in Zymolyase.

D Rimek, A P Garg, W H Haas, R Kappe

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2015
    Pooled it
  2. Review
  3. Microorganisms · 2023
    Review
  4. An Evaluation of the OLMJournal of fungi (Basel, Switzerland) · 2022
    Article
  5. Article
  6. Article
  7. Aspergillus PCR: one step closer to standardization.Journal of clinical microbiology · 2010
    Article
  8. Article
  9. Article
  10. False-positive results and contamination in nucleic acid amplification assays: suggestions for a prevent and destroy strategy.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2004
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

D RimekHygiene Institute, Children's Hospital, University of Heidelberg, Heidelberg, Germany. dagmar_rimek@ukl.uniheidelberg.de
A P Garg
W H Haas
R Kappe

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

When different preparations of Zymolyase were included in the pretreatment protocol of a panfungal PCR assay using a primer system for the 18S rRNA gene, an amplification product occurred in negative controls. The amplified fragment showed 100.0% sequence identity to the Saccharomyces sensu stricto complex and Kluyveromyces lodderae. Lyticase, lysing enzymes, and proteinase K appeared to be free from fungal DNA.

Indexed as

Drug ContaminationGlucan Endo-1,3-beta-D-GlucosidaseDNA, FungalDNA PrimersDNA, RibosomalKluyveromycesPolymerase Chain ReactionRNA, Ribosomal, 16SSaccharomycesDNA, FungalDNA PrimersDNA, RibosomalGlucan Endo-1,3-beta-D-GlucosidaseRNA, Ribosomal, 16S

Identifiers

PMID9986868
PMCPMC84574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.